Is the pharma industry particularly vulnerable to inflation?

The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health. However, Ben Hargreaves finds that greater pressure over drug pricing has emerged alongside inflation, effectively limiting the industry’s ability to price away the pain.